Monday, September 29, 2014 10:23:12 PM
Stryker license represents WiLAN’s first in medical field
OTTAWA, Canada – September 29, 2014 – Top intellectual property licensing company, WiLAN (TSX:WIN) (NASD:WILN), today announced that a wholly-owned subsidiary of the company has granted Stryker Corporation (“Stryker”) a license to certain patents related to medical stent technology. WiLAN secured the rights to license the patents through an agreement executed in June 2014.
“We are pleased that Stryker has signed this license,” said Jim Skippen, President & CEO. “This license agreement demonstrates our ability to develop and execute licensing programs in new markets such as medical technologies. It also demonstrates our ability to generate timely results for our partners.”
The consideration to be paid by Stryker to WiLAN and all other terms of the license agreement are confidential.
Recent QTRHF News
- Over C$5 Million Contract Awarded to Enforcement Solution Provider • AllPennyStocks.com • 03/07/2024 01:00:00 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM